Tag: common shares

TORONTO, July 04, 2025 (GLOBE NEWSWIRE) -- Petrolympic Ltd. (TSX-V: PCQ) (OTC:PCQRF) (the “Company”), announces that a total of 2,100,000 options to purchase common shares of the Company have been granted to directors and officers of the Company at an exercise price of $0.10 per share, expiring on July 4, 2030.

TORONTO, July 04, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that it has filed a preliminary short form base shelf prospectus with the securities regulatory authorities in each of the provinces of Canada, except Québec (the “Securities Regulators”).

TORONTO, Canada, July 04, 2025 (GLOBE NEWSWIRE) -- Canadian General Investments, Limited (CGI) (TSX:CGI) (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at June 30, 2025 was $70.37 resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 2.3% and 14.3%, respectively. These compare with the 10.2% and 26.4% returns of the benchmark S&P/TSX Composite Index on a total return basis for the same periods.

Half-year statement of the liquidity contract
As of June 30, 2025

VANCOUVER, British Columbia, July 02, 2025 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB: DMGGF) (FRANKFURT: 6AX) ("DMG" or the "Company"), a vertically integrated blockchain and data center technology company, today announces its preliminary operational results for June 2025:

MONTREAL, July 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it has entered into a binding arrangement agreement with CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products, whereby the Purchaser will acquire all the issued and outstanding common shares of the Company for US$3.01 per share in cash plus one contingent value right (“CVR”) per share for additional aggregate cash payments of up to US$1.19 per CVR if certain milestones as described below are achieved (the “Transaction”). The total Transaction consideration, assuming full payment of the CVRs, is US$254 million.

VANCOUVER, British Columbia, July 02, 2025 (GLOBE NEWSWIRE) -- Commodities & Resources PTE Ltd. (the “Acquiror"), a private investment company incorporated in Singapore, announces that on April 8, 2025, the Acquiror acquired Common Shares of Belmont Resources Inc. (TSX-V: BEA)(the “Issuer”). The Issuer completed a private placement of Common Shares, issuing a total of 4,000,000 shares to the Acquiror at a price of $0.045 per share for proceeds of $180,000 (the “Private Placement”).